scholarly article | Q13442814 |
P50 | author | Benedito Antônio Lopes da Fonseca | Q45879669 |
P2093 | author name string | Danielle Malta Lima | |
Sérgio Oliveira De Paula | |||
Rafael Freitas de Oliveira França | |||
Alessandra Cristina Gomes-Ruiz | |||
P2860 | cites work | Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine | Q40699429 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Dengue virus | Q476209 |
P1104 | number of pages | 9 | |
P304 | page(s) | 2215-2223 | |
P577 | publication date | 2008-11-12 | |
P1433 | published in | Archives of Virology | Q2860564 |
P1476 | title | A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge | |
P478 | volume | 153 |
Q40342245 | A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection |
Q33968024 | DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III. |
Q27304342 | Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes |
Q40342715 | Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection |
Q40225317 | Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus |
Q39118535 | Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts |
Q39668466 | Genotype-specific neutralization and protection by antibodies against dengue virus type 3. |
Q33961878 | Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines. |
Q37904025 | Next generation dengue vaccines: a review of candidates in preclinical development |
Q43296072 | Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo. |
Q35009119 | Progress towards a dengue vaccine |
Q56960671 | Recent Developments in Recombinant Protein-Based Dengue Vaccines |
Q38075857 | Recent advances in molecular medicine techniques for the diagnosis, prevention, and control of infectious diseases |
Q39187784 | Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design |
Q39470840 | Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination |
Q37903445 | The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease |
Search more.